跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Metsita - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Metsita
Approved
STANDARD
Metsita
Hetero Labs Limited (Unit-V, Block-VB)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d057732d0d5eea4e
Company
Hetero Labs Limited (Unit-V, Block-VB)
Type
Standard
Approval Details
Approval Id
d057732d0d5eea4e
Drug Approval Philippines Name
Metsita
Product Name
Metsita
Registration Number
DRP-10943-01
Brand Name
Metsita
Generic Name
Sitagliptin (as hydrochloride) + Metformin Hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg/1 g
Manufacturer
Hetero Labs Limited (Unit-V, Block-VB)
Importer
Camber Pharmaceuticals, Inc
Distributor
2MG Incorporated
Importer Detail Path
/organization/camber-pharmaceuticals-inc
Issuance Date
24 March 2022
Expiry Date
21 December 2026
Pharmacologic Category
Antidiabetic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d057732d0d5eea4e
Type
Standard
Back to Philippines FDA Approvals